NeurTX provides a noninvasive, image-guided neuromodulation platform for precise, multifocal treatment of neural tracts and circuits. Its proprietary MiNT™ technology, enhanced by AI-driven personalization, enables real-time targeting and dose monitoring to improve outcomes for neurological and mental health disorders.
Funding
Funding not disclosed
Founders
Product
Problem
Current neuromodulation therapies for neurological and mental health disorders are limited by their inability to precisely target and repair damaged neural tracts and circuits throughout the brain. Existing modalities like TMS lack deep brain targeting capabilities, Focused Ultrasound Stimulation (FUS) carries potential thermal risks and requires active MRI guidance, and Deep Brain Stimulation (DBS) is an invasive surgical procedure with limited scope. These limitations prevent a comprehensive, noninvasive approach to treating a wide spectrum of brain conditions.
Solution
NeurTX offers a noninvasive, image-guided neuromodulation therapy platform utilizing its proprietary MiNT™ technology. This system enables selective, multifocal treatment of entire neural tracts and circuits, addressing limitations of current therapies. The platform integrates AI-assisted personalization to optimize treatment parameters and improve patient response and remission rates. By providing image-guided treatment planning with real-time targeting and monitoring of dose and response, MiNT™ aims to deliver effective, biomarker-based therapies for a broad range of neurological and mental health disorders in an office or mobile setting.
Target Audience
The primary target audience includes neurologists, psychiatrists, and other clinicians treating patients with neurological and mental health disorders, as well as healthcare systems seeking advanced, noninvasive therapeutic options.
Features
- Noninvasive, image-guided neuromodulation for selective and multifocal treatment of brain tracts and circuits.
- MiNT™ technology provides real-time targeting, dose monitoring, and response verification.
- AI-assisted personalization engine for optimizing treatment parameters and patient outcomes.
- Scalable, all-in-one solution deployable in clinical office or mobile settings.
- Potential for biomarker-based treatment delivery for diverse neurological and mental health conditions.